NHS to Offer Improved Stop Smoking Pill in England

Nov.15.2024
NHS to Offer Improved Stop Smoking Pill in England
NHS will start offering an "improved" stop smoking pill to tens of thousands of people in England who want to quit cigarettes.

According to a recent report by the BBC, the National Health Service (NHS) in the UK will begin offering an "improved" stop smoking pill to tens of thousands of people in England who are looking to quit smoking.

 

The NHS has stated that Varenicline is as effective as e-cigarettes and more effective than nicotine replacement gum or patches.

 

This medication can suppress nicotine addiction and was previously marketed under the brand name Champix on the NHS several years ago. However, it was withdrawn due to some impurity issues. The new version has now been approved as safe.

 

Officials stated that e-cigarettes are sometimes provided, typically by local NHS stop smoking services, with an initial e-cigarette starter kit provided for approximately two weeks.

 

Varenicline is a prescription medication, which means people cannot purchase it over the counter at a pharmacy or supermarket and instead need to see their general practitioner (GP) or NHS stop smoking service to obtain it. It works by reducing cravings for nicotine and blocking its effects on the brain, while also helping to alleviate withdrawal symptoms such as irritability or difficulty sleeping.

 

The NHS states that it has been proven to help approximately one quarter of people quit smoking for at least six months when used in conjunction with behavioral support, such as counseling. The study suggests that this could help over 85,000 people quit smoking each year and potentially prevent around 9,500 smoking-related deaths in the next five years.

 

Health and Social Care Secretary Wes Streeting said: "The rollout of this pill can save the NHS millions of pounds, save appointments to help other patients be seen faster and save lives."

 

NHS CEO Amanda Pritchard announced at the annual NHS Providers conference that this drug could be a "game-changer" for those looking to quit smoking.

 

Due to e-cigarettes not being licensed as medication, general practitioners are unable to prescribe e-cigarettes for individuals attempting to quit smoking unless approved by the local NHS. However, some local governments do indeed provide e-cigarettes for smokers wanting to quit.

 

The guidelines suggest that people first try to obtain licensed smoking cessation medications, even though e-cigarettes are recognized as a smoking cessation aid. The harms of e-cigarettes are far less than smoking.

 

However, health experts unanimously agree that people should not start using e-cigarettes unless it is for smoking cessation.

 

Hazel Cheeseman, chief executive of Action on Smoking and Health, said access to services was variable.

 

"Wherever a smoker lives, they should be able to access the most effective forms of treatment to help them stop," she said.

 

"Improving access to varenicline will be a positive step forward to help prevent the tens of thousands of deaths caused by smoking. However, a drug alone will not transform smoking rates. Services are needed to support smokers and prescribe these products."

 

"The NHS has done a good job in setting up in-hospital support to help people quit smoking, which complements the services provided in the community, said Hazel Cheeseman. "But gaps remain around the country, with services often in peril as local NHS organizations try to balance the books."

 

Product | Brands Like Off-Stamp and SKE Launch Clear-Tank E-Cigarettes in UK and US Markets
Product | Brands Like Off-Stamp and SKE Launch Clear-Tank E-Cigarettes in UK and US Markets
Several new e-cigarette products featuring clear-tank designs have recently entered the market, including the Off-Stamp X Cube Crystal Cube 35K in the U.S. and the SKE Crystal Edge X in the UK. These models offer increased puff counts and e-liquid capacity, with the transparent tank as a key design highlight.
Jul.30 by 2FIRSTS.ai
Interview with NASTY Founder: How a Market-Specific Brand Strategy Led to Rapid Success in South Africa
Interview with NASTY Founder: How a Market-Specific Brand Strategy Led to Rapid Success in South Africa
In an interview with 2Firsts, NASTY founder Pak Din explains how the brand quickly rose to the top of South Africa’s vape market by leveraging early planning and a localized strategy, successfully seizing the first-mover advantage in this emerging market.
Jul.03
Smoking Rates Rise in Australia After Vape Ban, Driven by 18–24 Age Group
Smoking Rates Rise in Australia After Vape Ban, Driven by 18–24 Age Group
According to Roy Morgan data, smoking rates in Australia have increased following the mid-2024 vape ban. Usage of factory-made cigarettes and e-cigarettes rose significantly among the 18–24 age group, offsetting improvements seen in other age groups.
Jul.01 by 2FIRSTS.ai
PMI Launches IQOS ILUMA i Series in Saudi Arabia to Support a Smoke-Free Future
PMI Launches IQOS ILUMA i Series in Saudi Arabia to Support a Smoke-Free Future
Philip Morris International (PMI) has launched its next-generation heated tobacco products, the IQOS ILUMA i series, in Saudi Arabia, debuting with two devices: ILUMA i PRIME and ILUMA i.
Jul.09 by 2FIRSTS.ai
Philip Morris International invests in smoke-free electronic devices to reduce health risks.
Philip Morris International invests in smoke-free electronic devices to reduce health risks.
PMI invests in smoke-free electronic devices to reduce health risks caused by tobacco combustion, facing regulatory challenges and black market effects.
Jun.12 by 2FIRSTS.ai
Singapore Launches Anti-Vaping Campaign Using Satirical Designs to Warn Teens of Risks
Singapore Launches Anti-Vaping Campaign Using Satirical Designs to Warn Teens of Risks
Singapore’s Health Promotion Board and TBWA\Singapore launched the “Don’t Toy With Your Life” anti-vaping campaign, using satirical toy-like designs to expose vaping risks. The campaign spans digital media and public transport, targeting youth vaping and will run until August 2025 on popular social and streaming platforms.
Jul.11 by 2FIRSTS.ai